Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020 $ 34,305 $ 58 $ 128,771 $ (94,354) $ (170)
Beginning balance, Shares at Dec. 31, 2020   11,538,998      
Exercise of stock options 213   213    
Exercise of stock options, Shares   60,600      
Repurchase of common stock (2,192)   (2,192)    
Repurchase of common stock, Shares   (56,162)      
Issuance of common stock from RSUs vested, Shares   24,332      
Issuance of common stock in connection with exercise of warrants 8   8    
Issuance of common stock in connection with exercise of warrants, Shares   50,716      
Stock-based compensation 1,375   1,375    
Other comprehensive income (loss) (17)       (17)
Net income 79     79  
Ending balance at Mar. 31, 2021 33,771 $ 58 128,175 (94,275) (187)
Ending balance, Shares at Mar. 31, 2021   11,618,484      
Beginning balance at Dec. 31, 2021 33,815 $ 58 132,780 (98,785) (238)
Beginning balance, Shares at Dec. 31, 2021   11,703,430      
Exercise of stock options $ 13   13    
Exercise of stock options, Shares 8,528 8,528      
Repurchase of common stock $ (1,634)   (1,634)    
Repurchase of common stock, Shares (57,623,000) (57,623)      
Issuance of common stock from RSUs vested, Shares   22,755      
Issuance of common stock for acquisition $ 14,266 $ 3 14,263    
Issuance of common stock for acquisition, Shares   464,540      
Stock-based compensation 1,855   1,855    
Other comprehensive income (loss) 73       73
Net income 387     387  
Ending balance at Mar. 31, 2022 $ 48,775 $ 61 $ 147,277 $ (98,398) $ (165)
Ending balance, Shares at Mar. 31, 2022   12,141,630